Methylphenidate transdermal system (MTS) in the treatment of adult ADHD

Trial Profile

Methylphenidate transdermal system (MTS) in the treatment of adult ADHD

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Feb 2015

At a glance

  • Drugs Methylphenidate (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 29 Nov 2011 Actual end date (April 2009) added as reported by ClinicalTrials.gov.
    • 29 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Nov 2011 Actual patient number chaned from 80 to 67 according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top